Accepting new patients (614) 430-8022 7965 N High St, Suite 205
Optimed Immunology
Patient Portal Schedule Consultation

What is Cinryze?

Cinryze is an intravenous C1 esterase inhibitor for HAE prophylaxis. As one of the original IV C1 inhibitor prophylactic options, it remains an effective therapy for patients who prefer IV administration or who tolerate it better than subcutaneous alternatives.

What it treats

Cinryze is FDA-approved for the following indications:

  • Routine prophylaxis against HAE attacks in adult and pediatric patients

How it is administered

Cinryze is administered intravenously every three to four days. Many patients are trained for self-administration at home; others receive infusions through home health.

Patient assistance & support

The manufacturer offers a patient support program — Takeda OnePath — that can help with insurance navigation, copay assistance for eligible patients, nursing support, and ongoing education. More information is available at https://www.takedapatientsupport.com.

Coordination at Optimed Immunology

Treatment with Cinryze is initiated and monitored by Dr. McNeil. Prior authorizations are handled in-house — patients are not asked to navigate insurance approvals on their own. Infusion logistics are coordinated through trusted partner infusion providers — including Horizon Infusions, where the practice is co-located — or arranged for home infusion when appropriate. The team handles scheduling, nursing coordination, and prior-authorization renewals.

A note on age: The FDA indications above may include pediatric or adolescent age groups. Optimed Immunology's clinical practice is focused on adults. If you are seeking care for a minor, please contact the office and we can advise on referral options.

Important safety note: This page is not a substitute for the FDA prescribing information. Risks, contraindications, drug interactions, and required monitoring vary by patient. The official manufacturer website (https://www.cinryze.com) provides the most current full prescribing and safety information. Treatment decisions and monitoring are individualized — please discuss with Dr. McNeil whether Cinryze is appropriate for your situation.

Medically reviewed

Donald L. McNeil, MD · Board Certified in Allergy & Immunology and Internal Medicine

Last reviewed: November 2025 · Sources: FDA prescribing information · manufacturer label · AAAAI · ACAAI · relevant clinical guidelines

This page is provided for educational purposes only and is not medical advice. If you have an emergency, call 911.

Have questions about Cinryze?

Treatment selection is a shared decision. Schedule a consultation with Dr. McNeil to discuss whether Cinryze is appropriate for you.